PHARMANIAGA BHD (KLSE: 7081)

PHARMANIAGA BHD

KLSE: 7081 (PHARMA)

最近更新时间: 2天之前, 4:24AM

0.230

0.01 (2.22%)

加入群组

前收盘价格	0.225
收盘价格	0.230
成交量	4,217,700
平均成交量 (3个月)	3,289,405
市值	331,482,880

市盈率 (P/E TTM)	2.56
预期市盈率 (P/E Forward)	7.50
价格/销量 (P/S)	0.090
股市价格/股市净资产 (P/B)	0.910

52周波幅	0.200 (-13%) — 0.470 (104%)
利润日期	19 Aug 2025 - 25 Aug 2025

市场趋势

		短期	中期
行业	Medical Distribution (MY)	混合的	混合的
	Medical Distribution (全球的)	看跌	看跌
股票	PHARMA	混合的	看涨

AIStockmoo 评分

-0.3

分析师共识	NA
内部交易活动	NA
价格波动	0.5
技术平均移动指标	1.0
技术振荡指标	-2.5
平均	-0.33

相关股票

股票	市值	DY	P/E（TTM）	P/B
PHARMA	331 M	-	2.56	0.910
BCMALL	20 M	-	-	0.180
AHEALTH	2 B	4.02%	22.40	1.91

Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia, and Other countries, of which key revenue is derived from Malaysia.
部门	Healthcare
行业	Medical Distribution
投资方式	Small Value
内部持股比例	59.26%
机构持股比例	9.72%

所有权

姓名	日期	持有股份
Dasar Technologies Sdn. Bhd.	31 Mar 2023	9,750,000 (0.74%)
Lew (U Sing)	31 Mar 2023	8,280,000 (0.63%)
Lodin bin Wok Kamaruddin	31 Mar 2023	6,100,000 (0.47%)
Yong (Siew Yoon)	31 Mar 2023	4,060,000 (0.31%)
Public Gold Marketing Sdn. Bhd.	31 Mar 2023	3,900,000 (0.30%)
Poh (Seng Kian)	31 Mar 2023	3,500,000 (0.27%)
Lembaga Tabung Amanah Melaka	31 Mar 2023	3,500,000 (0.27%)
Yayasan Ltat	31 Mar 2023	2,980,000 (0.23%)

该时间范围内无数据。

日期	类型	细节
27 Jun 2025	TheEdge	Wary investors eye more recovery clarity from Pharmaniaga
18 Jun 2025	公告	PHARMA - Notice of Rights Entitlement (Ratio)
18 Jun 2025	公告	PHARMA - Notice of Rights Entitlement
18 Jun 2025	公告	General Meetings: Outcome of Meeting
18 Jun 2025	TheEdge	Pharmaniaga, Scientex, DNeX, MN Holdings, Guocoland, LGMS, Farm Price, Kobay
18 Jun 2025	TheEdge	Pharmaniaga eyes FY2025 revenue of RM4b, plots PN17 exit by 1Q next year
17 Jun 2025	公告	Change in Boardroom - ENCIK IZADDEEN BIN DAUD
17 Jun 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
17 Jun 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
17 Jun 2025	公告	Important Relevant Dates for Renounceable Rights
17 Jun 2025	公告	Rights Issue
17 Jun 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
16 Jun 2025	TheEdge	Perkeso could emerge as substantial shareholder of Pharmaniaga
09 Jun 2025	TheEdge	Izaddeen to leave Boustead Holdings, say sources
03 Jun 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
23 May 2025	TheEdge	Pharmaniaga gets three-month extension to implement regularisation plan
22 May 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
15 May 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
13 May 2025	TheEdge	Duopharma set for strong 1Q growth backed by approved products purchase list contracts — CGS International
07 May 2025	TheEdge	SD Guthrie, Pharmaniaga, I-Bhd, Capital A, Sarawak Cable, Kumpulan Jetson and Pavilion REIT
07 May 2025	TheEdge	Pharmaniaga’s 1Q net profit up 15% on higher sales and cost optimisation
07 May 2025	公告	Quarterly rpt on consolidated results for the financial period ended 31/03/2025
02 May 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
30 Apr 2025	TheSun	Pharmaniaga confident of exiting PN17, backed by resilient operations and forward strategies
29 Apr 2025	TheEdge	Pharmaniaga's auditor flags going concern uncertainty for third straight year
29 Apr 2025	公告	Annual Report & CG Report - 2024
29 Apr 2025	公告	CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE
29 Apr 2025	公告	AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : MATERIAL UNCERTAINTY RELATED TO GOING CONCERN
29 Apr 2025	TheEdge	S P Setia, Sime Darby Property, CIMB, GuocoLand, DXN, Pantech, Southern Score Builders, Pharmaniaga, Mudajaya, MyEG
28 Apr 2025	TheEdge	Duopharma bags another supply contract from Pharmaniaga
28 Apr 2025	公告	General Meetings: Notice of Meeting
28 Apr 2025	TheEdge	Nestlé Malaysia, Bursa Malaysia, BAT Malaysia, F&N, Rohas Tecnic, MKH, Meta Bright, Duopharma Biotech, Pintaras Jaya, Johor Plantations
18 Apr 2025	公告	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS
17 Apr 2025	TheEdge	Cover Story: LTAT moves forward despite challenges
17 Apr 2025	TheEdge	Cover Story: Healing old wounds and growing new income streams at Pharmaniaga
05 Apr 2025	TheEdge	LTAT moving forward despite challenges
02 Apr 2025	公告	PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
显示更多

5年平均股息收益率

6.92%

除息日	公告日期	支付日期	详情
08 Dec 2022	30 Nov 2022	06 Jan 2023	0.006 现金
09 Sep 2022	19 Aug 2022	04 Oct 2022	0.005 现金
07 Jun 2022	20 May 2022	06 Jul 2022	0.008 现金
07 Mar 2022	17 Feb 2022	05 Apr 2022	0.05 现金
06 Dec 2021	19 Nov 2021	29 Dec 2021	0.02 现金
07 Sep 2021	20 Aug 2021	30 Sep 2021	0.015 现金
04 Jun 2021	21 May 2021	06 Jul 2021	0.04 现金
30 Mar 2021	17 Mar 2021	22 Apr 2021	0.01 现金
04 Dec 2020	19 Nov 2020	29 Dec 2020	0.015 现金
07 Sep 2020	19 Aug 2020	06 Oct 2020	0.025 现金
04 Jun 2020	19 May 2020	30 Jun 2020	0.06 现金
11 Sep 2019	23 Aug 2019	11 Oct 2019	0.025 现金
03 Jun 2019	16 May 2019	27 Jun 2019	0.06 现金
08 Mar 2019	21 Feb 2019	10 Apr 2019	0.02 现金
03 Dec 2018	19 Nov 2018	03 Jan 2019	0.05 现金
03 Sep 2018	17 Aug 2018	18 Sep 2018	0.04 现金
30 May 2018	16 May 2018	20 Jun 2018	0.05 现金
13 Mar 2018	27 Feb 2018	28 Mar 2018	0.06 现金
29 Nov 2017	15 Nov 2017	15 Dec 2017	0.05 现金
29 Aug 2017	01 Sep 2017	18 Sep 2017	0.04 现金
29 May 2017	16 May 2017	07 Jun 2017	0.04 现金
07 Mar 2017	21 Feb 2017	17 Mar 2017	0.03 现金
05 Dec 2016	21 Nov 2016	15 Dec 2016	0.04 现金
02 Sep 2016	19 Aug 2016	20 Sep 2016	0.05 现金
01 Jun 2016	13 May 2016	28 Jun 2016	0.04 现金
01 Mar 2016	15 Feb 2016	25 Mar 2016	0.07 现金
09 Dec 2015	26 Nov 2015	21 Dec 2015	0.09 现金
01 Sep 2015	17 Aug 2015	15 Sep 2015	0.07 现金
01 Jun 2015	18 May 2015	25 Jun 2015	0.07 现金
09 Mar 2015	23 Feb 2015	26 Mar 2015	0.12 现金
05 Dec 2014	21 Nov 2014	30 Dec 2014	0.08 现金
05 Sep 2014	21 Aug 2014	24 Sep 2014	0.04 现金
29 May 2014	14 May 2014	16 Jun 2014	0.04 现金
10 Mar 2014	24 Feb 2014	02 Apr 2014	0.062 现金
03 Dec 2013	19 Nov 2013	24 Dec 2013	0.03 现金
30 Aug 2013	16 Aug 2013	24 Sep 2013	0.0341 现金
30 May 2013	15 May 2013	28 Jun 2013	0.075 现金
04 Mar 2013	18 Feb 2013	27 Mar 2013	0.1 现金
21 Nov 2012	06 Nov 2012	17 Dec 2012	0.1 现金
23 Aug 2012	08 Aug 2012	12 Sep 2012	0.075 现金
16 May 2012	03 May 2012	18 Jun 2012	0.075 现金
08 Mar 2012	21 Feb 2012	28 Mar 2012	0.21 现金
06 Jan 2012	21 Dec 2011	26 Jan 2012	0.09 现金
显示更多

每年股息收益率

年份	每年总股息 ($)	频率/年份	收益率 %
2023	0.006	1	1.56
2022	0.063	3	11.56
2021	0.085	4	11.49
2020	0.100	3	10.00
2019	0.155	4	37.62
2018	0.150	3	26.98
2017	0.160	4	17.39
2016	0.200	4	18.87
2015	0.350	4	27.52
2014	0.222	4	24.24
2013	0.239	4	26.87
2012	0.550	5	74.69
显示更多

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

请登录以添加到您的群组

AI 建议策略模板

自定义的价格提醒

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

请登录以添加到您的群组

已实现利润	-
未实现利润	-
收到股息 2025	-
利润总额	-
平均回报	-
数量(购买)	-
平均价格(购买)	-
数量(卖出)	-
平均价格(卖出)	-

请登录以添加到您的群组

没有符合您标准的股票

营业毛利率	3.53%
营业利益率 (TTM)	5.73%
稀释每股收益 (EPS TTM)	0.090
季度收入增长率 (YOY)	9.40%
季度盈利增长率 (YOY)	15.30%

流动比率 (MRQ)	0.640
营业现金流 (OCF TTM)	120.26 M
杠杆自由现金流 (LFCF TTM)	85.92 M

安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)